Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 May 23;13(6):1231. doi: 10.3390/life13061231

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Two-dimensional transthoracic echocardiographic views of case #3. (A); Left ventricular apical SAX view, illustrating hypertrabeculated apical portions in addition to deep intertrabecular recesses. (B); Color Doppler echocardiography, showing evidence of direct blood flow from the ventricular cavity into deep intertrabecular recesses. (C); Dilated aortic proximal ascending aorta. (D); Speckle tracking echocardiographic findings, compatible with myocardial performance impairment of all segments with GLS = −14.3%. (E,F); Coronary angiography showing on arrival and 2-week post-treatment results. (G); Cardiac magnetic resonance imaging, illustrating prominent non-compaction in left ventricular apical and lateral wall.

Two-dimensional transthoracic echocardiographic views of case #3. (A); Left ventricular apical SAX view, illustrating hypertrabeculated apical portions in addition to deep intertrabecular recesses. (B); Color Doppler echocardiography, showing evidence of direct blood flow from the ventricular cavity into deep intertrabecular recesses. (C); Dilated aortic proximal ascending aorta. (D); Speckle tracking echocardiographic findings, compatible with myocardial performance impairment of all segments with GLS = −14.3%. (E,F); Coronary angiography showing on arrival and 2-week post-treatment results. (G); Cardiac magnetic resonance imaging, illustrating prominent non-compaction in left ventricular apical and lateral wall.